跳至主要内容
临床试验/NCT03201432
NCT03201432已完成2 期

A Randomized Trial for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis: Drug Eluting Stents Versus Bare Metal Stents

Xiongjing Jiang0 个研究点目标入组 160 人开始时间: 2014年5月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160
主要终点
Stent restenosis rate 6 months after stenting

研究概览

简要总结

Stroke is one of the important causes of disability and death in the world, in which more than half were ischemic strokes. About 1/4 of the ischemic stroke occurred in the vertebral basilar artery system, especially when in the presence of extracranial proximal vertebral artery stenosis. Vertebral artery stenting is a minimally invasive method for the reconstruction of vertebral artery stenosis and the early clinical studies showed that it was feasible, safe and effective, but the high rate of restenosis has become a bottleneck restricting its development. Previous systematic review had suggested that the drug eluting stent might reduce the incidence of restenosis of vertebral artery. However, prospective randomized controlled trials comparing the efficacy of bare metal stents and drug eluting stents on the prevention of restenosis remains absent.

详细描述

60 patients were randomly assigned into DES and BES group to compare the safety and efficacy in the treatment of symptomatic extracranial vertebral artery stenosis with drug eluting stents (YINYI) and bare metal stents (Express SD), especially the stent restenosis rate after 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

No Masking

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic posterior circulation ischemia(Vertebral basilar artery system TIA or non-disabling ischemic stroke)result from the stenosis in the extracranial proximal vertebral artery stenosis.
  • Atherosclerotic extracranial proximal vertebral artery stenosis demonstrated by angiography(any of the following): 1) bilateral vertebral artery stenosis ≥70%, or vertebral artery stenosis ≥70% concomitant occlusion of contralateral vertebral artery; 2) superior lateral vertebral artery stenosis ≥70%; 3) non-superior lateral vertebral artery stenosis ≥50%, but the vertebral artery was directly extended to the posterior inferior cerebellar artery on this side and symptoms were related to insufficiency of the ipsilateral posterior inferior cerebellar artery.

排除标准

  • lesions characteristics (such as diffuse lesions) which was not suitable for interventional treatment, or unstable condition that cannot tolerate the interventional therapy;
  • vertebral artery stenosis caused by non atherosclerosis disease: Takayasu arteritis or other diseases;
  • severe stroke within 3 months;
  • contraindicated using contrast agents: such as chronic renal insufficiency or had serious contrast agents allergy history;
  • malignant tumor;
  • with Alzheimer's disease or mental illness previously or currently ;
  • patients or family members refuse the operation.

结局指标

主要结局

Stent restenosis rate 6 months after stenting

时间窗: 6 months

次要结局

  • Stent restenosis rate 3 months after stenting(3 months)
  • Stent restenosis rate 12 months after stenting(12 months)
  • The incidence of cardiovascular events (stroke, TIA, Miocardial infarction and death) 6 months after stenting(6 months)

研究者

发起方
Xiongjing Jiang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xiongjing Jiang

Professor

Chinese Academy of Medical Sciences, Fuwai Hospital

相似试验